Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
4.44B | 4.40B | 4.30B | 4.10B | 3.68B | Gross Profit |
1.41B | 1.34B | 1.27B | 1.14B | 876.00M | EBIT |
374.00M | 333.00M | 358.00M | 209.00M | -32.00M | EBITDA |
1.31B | 1.22B | 1.18B | 1.10B | 883.00M | Net Income Common Stockholders |
173.00M | 134.00M | 157.00M | 27.00M | -170.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
371.00M | 497.00M | 773.00M | 644.00M | 719.00M | Total Assets |
6.50B | 6.62B | 7.00B | 6.57B | 7.16B | Total Debt |
2.66B | 2.99B | 3.61B | 3.42B | 3.96B | Net Debt |
2.29B | 2.52B | 2.84B | 2.77B | 3.24B | Total Liabilities |
4.05B | 4.36B | 4.89B | 4.65B | 5.28B | Stockholders Equity |
2.45B | 2.26B | 2.10B | 1.92B | 1.88B |
Cash Flow | Free Cash Flow | |||
530.00M | 510.00M | 484.00M | 454.00M | 494.00M | Operating Cash Flow |
1.20B | 1.17B | 1.08B | 1.05B | 993.00M | Investing Cash Flow |
-654.00M | -525.00M | -704.00M | -192.00M | -1.01B | Financing Cash Flow |
-642.00M | -949.00M | -243.00M | -933.00M | -265.00M |
Cellcom Israel Ltd. announced the approval of a private issuance of 10 million options, intended to increase the company’s issued and paid-up capital. These options are designated for employees, managers, and consultants, highlighting the company’s emphasis on rewarding and motivating its internal stakeholders. This strategic move could boost employee engagement and retention, potentially strengthening the company’s industry position.
Cellcom Israel Ltd. has announced a meeting to discuss its annual financial report for 1999. The meeting will cover the company’s financial performance, strategic initiatives, market positioning, and future growth plans, including addressing potential challenges and regulatory issues. Shareholders will have the opportunity to engage with the company’s strategy, governance, and sustainability efforts, showcasing Cellcom’s commitment to transparency and delivering shareholder value.